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to care in Uganda: a factorial randomised controlled trial
Rhoda K Wanyenze, Moses R Kamya, Robin Fatch, Harriet Mayanja-Kizza, Steven Baveewo, Gregory Szekeres, David R Bangsberg, Thomas Coates, 
Judith A Hahn
Summary
Background HIV counselling and testing and linkage to care are crucial for successful HIV prevention and treatment. 
Abbreviated counselling could save time; however, its eﬀ ect on HIV risk is uncertain and methods to improve linkage 
to care have not been studied.
Methods We did this factorial randomised controlled study at Mulago Hospital, Uganda. Participants were randomly 
assigned to abbreviated or traditional HIV counselling and testing; HIV-infected patients were randomly assigned to 
enhanced linkage to care or standard linkage to care. All study personnel except counsellors and the data oﬃ  cer were 
masked to study group assignment. Participants had structured interviews, given once every 3 months. We compared 
sexual risk behaviour by counselling strategy with a 6·5% non-inferiority margin. We used Cox proportional hazards 
analyses to compare HIV outcomes by linkage to care over 1 year and tested for interaction by sex. This trial is 
registered with ClinicalTrials.gov (NCT00648232).
Findings We enrolled 3415 participants; 1707 assigned to abbreviated counselling versus 1708 assigned to traditional. 
Unprotected sex with an HIV discordant or status unknown partner was similar in each group (232/823 [27·9%] vs 
251/890 [28·2%], diﬀ erence –0·3%, one-sided 95% CI 3·2). Loss to follow-up was lower for traditional counselling 
than for abbreviated counselling (adjusted hazard ratio [HR] 0·61, 95% CI 0·44–0·83). 1003 HIV-positive participants 
were assigned to enhanced linkage (n=504) or standard linkage to care (n=499). Linkage to care did not have a 
signiﬁ cant eﬀ ect on mortality or receipt of co-trimoxazole. Time to treatment in men with CD4 cell counts of 250 cells 
per μL or fewer was lower for enhanced linkage versus standard linkage (adjusted HR 0·60, 95% CI 0·41–0·87) and 
time to HIV care was decreased among women (0·80, 0·66–0·96).
Interpretation Abbreviated HIV counselling and testing did not adversely aﬀ ect risk behaviour. Linkage to care 
interventions might decrease time to enrolment in HIV care and antiretroviral treatment and thus might aﬀ ect 
secondary HIV transmission and improve treatment outcomes.
Funding US National Institute of Mental Health.
Introduction
High coverage of counselling and testing is crucial to the 
success of HIV prevention and treatment programmes.1 
Uganda started the ﬁ rst voluntary HIV counselling and 
testing programme in Africa, expanding to all districts by 
2005; however, access to testing could still be improved.2 
Poor uptake of voluntary counselling and testing is a 
common problem worldwide3,4 and, in response, home-
based and provider-initiated HIV testing and counselling 
have been adopted widely.5–7 Home-based testing refers to 
testing provided to entire communities in their homes by 
door-to-door visits or to household members of HIV-
positive individuals. Provider-initiated testing refers to 
testing within a health-care setting that is initiated by a 
health provider to patients irrespective of their clinical 
diagnosis (as opposed to client-initiated or voluntary 
testing, which is instigated by the client). HIV testing in 
Uganda increased from 25% to 66% for women and 
from 21% to 45% for men between 2005 and 2011.2,8
A major challenge to the scale-up of provider-initiated 
HIV testing and counselling is the time needed to provide 
detailed counselling when faced with inadequate staﬃ  ng 
and other competing health-care priorities. Therefore, the 
Ugandan Ministry of Health developed a brief HIV 
counselling protocol in 2006,9 almost entirely removing 
individualised risk assessment and pre-test counselling, 
while retaining general prevention mes sages such as risk 
reduction options, HIV serostatus disclosure, and partner 
testing.9 Abbreviated counselling might reduce the time 
burden on providers and increase the numbers of patients 
tested for HIV; however, whether it compromises the 
eﬃ  cacy of sexual risk reduction aﬀ orded by traditional, 
individualised counselling is still unclear.10–14
After HIV diagnosis, rapid entry into care and initiation 
of antiretroviral therapy is needed to prevent secondary 
transmission and improve clinical outcomes; however, 
signiﬁ cant delays have been reported in prospective 
studies.15,16 Interventions to eliminate lags in entry into 
care could have an important eﬀ ect on reducing 
secondary HIV transmission. The enhanced linkage to 
care intervention was an adaptation of the case-
management linkage model, which resulted in a 
signiﬁ cantly higher rate of successful linkage to HIV 
care compared with passive referral.17
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We investigated the eﬀ ect of abbreviated versus 
traditional HIV counselling and testing on sexual risk 
behaviour and the eﬀ ect of enhanced linkage to HIV 
care versus standard paper-based linkage on several 
HIV outcomes.
Methods
Study design and participants
We did this factorial, randomised controlled trial at 
Mulago Hospital, a large national referral and teaching 
hospital in Uganda. The ﬁ rst comparison assessed the 
eﬀ ect of abbreviated HIV testing and counselling versus 
traditional testing and counselling on unprotected sex 
with an HIV discordant partner. The second comparison 
assessed the eﬀ ect of enhanced linkage versus standard 
linkage on enrolment in HIV care, receipt of prophylaxis 
for opportunistic infections, receipt of antiretroviral 
therapy, and mortality.
Participants were patients in four medical inpatient 
wards and four medical outpatient clinics of Mulago 
Hospital.15,16 Eligibility criteria were: age 18 years or older, 
never been tested for HIV or tested negative more than 
1 year before recruitment, lived within 25 km of Mulago 
Hospital, willing to have an HIV test, and suﬃ  cient 
cognitive ability. The institutional review boards of the 
University of California, Los Angeles (CA, USA); the 
University of California, San Francisco (CA, USA); and 
Makerere University School of Medicine (Kampala, 
Uganda) approved the study protocols and each 
participant provided written informed consent. An 
independent data and safety monitoring board met yearly 
to review study protocols, progress, and interim results. 
The full study protocol is available online.
Randomisation and masking
We randomly allocated patients to abbreviated HIV 
testing and counselling or traditional HIV testing and 
counselling (1:1) in blocks of 100. Research counsellors 
were provided with the allocation through computer-
generated randomisation after a baseline behavioural 
interview. To retain a roughly equal number of HIV-
positive and HIV-negative participants for 1 year, HIV-
negative participants were randomly assigned to 
follow-up or no follow-up (roughly 1:1). HIV-positive 
participants were randomly assigned to enhanced linkage 
to care or standard linkage to care (1:1); all were followed 
up for 1 year. These randomisations were computer-
generated after HIV status was assessed. All study 
personnel except counsellors and the data oﬃ  cer were 
masked to study group assignment.
Procedures
The abbreviated intervention was based on the Ugandan 
provider-initiated HIV testing and counselling protocols,9 
and included a brief introduction to the beneﬁ ts of HIV 
testing, the right to refuse testing, the importance of 
disclosure and partner testing, risk reduction options, 
and—in the event of a positive test result—available 
follow-up services. The participant was reassured that the 
test was being oﬀ ered routinely and the session 
concluded with a question and answer period.
For the traditional intervention, we used the 
traditional HIV testing and counselling model that has 
been eﬃ  cacious in east Africa and the Caribbean,18 
endorsed by WHO, and widely implemented in 
voluntary counselling and testing centres in Uganda.19 
The session included orientation, a personalised risk 
assessment, the development of a risk reduction plan 
appropriate for the patient’s HIV status and social 
situation, and advice for status disclosure and partner 
referral. The session concluded with a question and 
answer period.
The enhanced linkage to care intervention was based 
on case-management referral and included: (1) 
counselling to reduce barriers to linkage to care; (2) 
assisted disclosure of HIV status to people who could 
provide social support; (3) introduction to the Mulago 
Immune Suppression Syndrome clinic and staﬀ , and 
scheduling a follow-up appointment; and (4) a reminder 
via telephone or home visit (if no telephone) 1 week 
before the scheduled appointment. If the appointment 
was missed, up to four telephone call reminders or two 
home visits were attempted. The participants were 
allowed to opt out of HIV status disclosure. The standard 
linkage to care protocol involved an explanation of the 
available services, opening hours, and locations of the 
Immune Suppression Syndrome clinic and other nearby 
clinics. The participant was given information on paper 
about referral and the clinic.
Participants who were HIV-negative at baseline 
according to the Determine test (Abbott Laboratories; 
Abbott Park, IL, USA) were considered negative, and 
those who tested positive for both Determine and STAT-
PAK (Chembio Diagnostics; Medford, NY, USA) tests 
were considered positive. Patients who tested positive by 
Determine but negative by STAT-PAK were tested with 
the Uni-Gold Recombigen test (Trinity Biotech, USA) 
and with the Amplicor DNA PCR qualitative test (Roche 
Diagnostics, Branchburg, NJ, USA).20 CD4 cell counts 
were taken at baseline, 6 months, and 12 months for 
HIV-positive participants. HIV testing was done at 
Mulago Hospital; CD4 testing was done at the Makerere 
University–Johns Hopkins University laboratory.
Participants completed a 30 min structured survey, 
given by an interviewer, once every 3 months for 1 year. 
Baseline surveys included participant demographics, 
HIV testing history, and concerns about HIV disclosure; 
follow-up surveys included assessment of HIV care and 
HIV status disclosure. Both baseline and follow-up 
interviews included detailed questions about up to ﬁ ve 
sexual partners in the past 3 months, including the 
perceived HIV status of each partner and frequency of 
condom use (always, sometimes, never) with each 
partner.
For the protocol see http://
musph.ac.ug/study-maksph/
resources/downloads-repository/
category/16-maksph-
application-forms? 
download=88:vct-
protocolseptember2009
Articles
www.thelancet.com/lancetgh   Vol 1   September 2013 e139
Outcomes
The primary outcome variable for the comparison of HIV 
testing and counselling strategies was any unprotected sex 
with a potentially HIV-discordant partner (risky sexual 
behaviour) in the year after testing. A partner was deﬁ ned 
as potentially HIV discordant if the participant had tested 
HIV-negative and reported that the partner was HIV-
positive, if the participant had tested HIV-positive and 
reported that the partner was HIV-negative, or if the 
participant did not know the HIV status of the partner.
Outcome variables for the comparison of linkage to 
care were receipt of HIV care, receipt of co-trimoxazole 
for opportunistic infection prophylaxis, median time to 
start of antiretroviral therapy (in patients with baseline 
CD4 cell count ≤250 cells per mL), and 3-month and 
1-year mortality. Receipt of HIV care was ascertained by 
asking if the participant had seen a medical provider in 
the past 3 months, and if so, which clinic they last visited. 
Clinics were classiﬁ ed post-hoc as HIV clinics or not 
(without knowledge of study group). Mortality was 
assessed by reports made by contacts encountered at 
home visits for tracking missing participants.
Covariates regarded as potential confounders included 
participant demographics, history of medical care, sexual 
behaviours, alcohol use, and site of recruitment. 
We created a household wealth index using principal 
components analysis—a method for reducing the 
number of correlated variables into a smaller number of 
dimensions—to group participants based on ownership 
of durable goods, housing quality, and available energy 
sources,21 and created three categories: low (0–40%), 
middle (41–80%), and high (81–100%).
Statistical analysis
On the basis of our previous work, we estimated that 
recruiting 2000 participants would provide 1268–1384 
people followed up for 1 year, assuming that 58% would 
test HIV-positive, mortality at 1-year would be 30–40% 
among those with HIV and 20% among those without 
HIV, and 5% would be lost to follow-up.15 Assuming that 
40% would engage in risky sexual behaviour, we estimated 
that we would have 80% power to reject a null hypothesis 
of the inferiority of abbreviated HIV testing and 
counselling with a diﬀ erence of 6·5% or less. During the 
Figure 1: Trial proﬁ le
Loss to follow-up includes participants who moved out of the area, who could not be located, and who did not complete their 12 month interview within the study 
follow-up window (within 1 month of due date).
5214 participants assessed
for eligibility 
1799 excluded
1327 ineligible
472 declined
3415 enrolled
1708 assigned to traditional HIV counselling and testing1707 assigned to abbreviated HIV counselling and testing
14 declined or 
ineligible 
(excluded from 
analysis)
506 HIV-positive 1187 HIV-negative 497 HIV-positive 1199 HIV-negative 11 declined or ineligible
(excluded from
analysis)
1 lost file
538 assigned to
follow-up
661 assigned to 
no follow-up
525 assigned to
follow-up
662 assigned to
no follow-up
258 assigned to
enhanced linkage
to care
39 died
27 lost to
follow-up
192 in follow-up
at 12 months
248 assigned to
standard linkage
to care
38 died
28 lost to
follow-up
182 in follow-up
at 12 months
20 died
47 lost to
follow-up
458 in follow-up
at 12 months
246 assigned to
enhanced linkage
to care
35 died
13 lost to
follow-up
198 in follow-up
at 12 months
251 assigned to
standard linkage
to care
28 died
19 lost to
follow-up
204 in follow-up
at 12 months
18 died
32 lost to
follow-up
488 in follow-up
at 12 months
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Abbreviated HIV 
counselling and testing 
(n=1031)
Traditional HIV 
counselling and testing 
(n=1035)
Enhanced linkage 
to care
(n=504)
Standard linkage 
to care
(n=499)
HIV positive 506 (49%) 497 (48%) 504 (100%) 499 (100%)
Median CD4 cell count (IQR; cells per μL) ·· ·· 257 (126–427) 317 (140–503)
Median age (IQR; years) 30 (25–38) 30 (25–38) 31 (27–38) 32 (27–38)
Men 456 (44%) 424 (41%) 187 (37%) 191 (38%)
Marital status
Married 442 (43%) 427 (41%) 218 (43%) 200 (40%)
Previously married 323 (31%) 337 (33%) 218 (43%) 217 (43%)
Never married 265 (26%) 271 (26%) 68 (13%) 82 (16%)
Missing data 1 (<1%) 0 (0%) 0 (0%) 0 (0%)
Education
No formal education 55 (5%) 50 (5%) 31 (6%) 32 (6%)
Primary school 464 (45%) 477 (46%) 278 (55%) 253 (51%)
Secondary or tertiary school 510 (49%) 507 (49%) 194 (38%) 213 (43%)
Missing data 2 (<1%) 0 (0%) 0 (0%) 0 (0%)
Employment
Labourer 344 (33%) 327 (32%) 159 (32%) 178 (36%)
Business, sales, or technical 438 (43%) 464 (45%) 204 (40%) 227 (45%)
Other 248 (24%) 244 (24%) 141 (28%) 94 (19%)
Household wealth
High 142 (14%) 180 (17%) 59 (12%) 77 (15%)
Middle 390 (38%) 421 (41%) 197 (39%) 180 (36%)
Low 494 (48%) 432 (42%) 244 (48%) 241 (48%)
Missing data 5 (<1%) 2 (<1%) 4 (1%) 1 (<1%)
Frequency that household members go hungry
Often 26 (3%) 27 (3%) 16 (3%) 14 (3%)
Sometimes 133 (13%) 111 (11%) 62 (12%) 72 (14%)
Seldom 103 (10%) 98 (9%) 62 (12%) 50 (10%)
Never 750 (73%) 778 (75%) 348 (69%) 352 (71%)
Missing data 19 (2%) 17 (2%) 16 (3%) 11 (2%)
Recruitment site
Inpatient ward 196 (19%) 206 (20%) 90 (18%) 95 (19%)
Outpatient ward 695 (67%) 708 (68%) 325 (64%) 325 (65%)
Emergency or casualty department 140 (14%) 121 (12%) 89 (18%) 79 (16%)
Previous treatment in a clinic
None 746 (72%) 748 (72%) 372 (74%) 364 (73%)
>12 months ago 17 (2%) 13 (1%) 8 (2%) 2 (<1%)
≤12 months ago 123 (12%) 135 (13%) 60 (12%) 65 (13%)
Don’t know or declined 145 (14%) 139 (13%) 64 (13%) 68 (14%)
Number of sexual partners in the past 12 months
0 256 (25%) 241 (23%) 139 (28%) 117 (23%)
1 552 (54%) 560 (54%) 268 (53%) 263 (53%)
2–5 201 (19%) 214 (21%) 86 (17%) 107 (21%)
>5 16 (2%) 10 (1%) 6 (1%) 6 (1%)
Missing data 6 (1%) 10 (1%) 5 (1%) 6 (1%
Any unprotected sex in the past 3 months 510 (49%) 545 (53%) 248 (49%) 246 (49%)
Last alcohol use
Never 459 (45%) 443 (43%) 186 (37%) 187 (37%)
>3 months ago 269 (26%) 278 (27%) 156 (31%) 141 (28%)
≤3 months ago 299 (29%) 308 (30%) 160 (32%) 168 (34%)
Missing data 4 (<1%) 6 (1%) 2 (<1%) 3 (1%)
Data are n (%) or median (IQR). 
Table 1: Baseline characteristics
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study, HIV prevalence and mortality were lower than 
previously reported, consistent with trends of HIV 
prevalence in newly diagnosed patients admitted to 
hospital in Uganda. Therefore, to study the projected 
number of HIV-positive participants (638–754) for the 
comparison of access to care, we screened a larger 
number of people than originally planned, and stopped 
enrolment at the end of June, 2011, with 1003 HIV-positive 
people enrolled: 776 were in follow-up by July, 2012.
Planned analyses included non-inferiority tests of the 
proportion of participants reporting sexual risk behaviour 
in the year after HIV testing, in HIV-positive and HIV-
negative participants. We would reject the null hypothesis 
of greater risky sexual behaviour in the abbreviated HIV 
testing and counselling group if the upper bound of the 
one-sided 95% CI for the diﬀ erence in proportions was 
less than 6·5%. This analysis was done in both intention-
to-treat and per-protocol populations using total duration 
of less than 30 min to deﬁ ne abbreviated HIV testing and 
counselling. We compared linkage to care approaches 
with Cox proportional hazards analyses, using a 
signiﬁ cance level of 0·048 to account for one interim 
analysis (done by JAH and RF in May, 2011, and shared 
with the data and safety monitoring board; all other study 
personnel remained masked to allocation). We did 
additional, post-hoc analyses to assess: (1) the eﬀ ect of 
missing interviews on our analysis of HIV counselling 
and testing using multiple (ﬁ ve) imputations by chained 
equations, assuming data were missing at random; (2) 
the eﬀ ect of adjusting for variables that were not equally 
distributed between randomised groups; (3) the eﬀ ect of 
HIV counselling and testing strategy on sexual risk at 
each timepoint; (4) the eﬀ ect of HIV counselling and 
testing strategy on study retention; (5) whether there was 
interaction between linkage to care group and sex, using 
the likelihood ratio test with a signiﬁ cance of p less than 
0·10; and (6) the eﬀ ect of HIV counselling and testing 
strategy on entry into HIV care, controlling for linkage to 
care group.
Role of the funding source
The sponsor had no role in designing the study, 
analysing data, collecting data, interpreting the results, 
writing the report, or the decision to submit the paper 
for publication. The corresponding author had complete 
access to all the data.
Results
From May, 2008, to June, 2011, we screened 5214 people. 
1327 were ineligible and 472 declined to participate 
(ﬁ gure 1); 3415 were enrolled. After assignment to a 
counselling strategy, 26 people were excluded from the 
study. Of the remaining 3389 participants, 1003 (30%) 
were HIV-positive and 2386 (70%) were HIV-negative. 
Of the HIV-negative participants, 1323 were randomly 
assigned to be excluded from follow-up, leaving 2066 
HIV-negative and HIV-positive participants in follow-up. 
Of the 2066 people in follow-up, 178 (9%) died, 166 (8%) 
moved or were lost to follow-up, and 1722 (83%) were still 
in follow-up at 1 year.
Of the 2066 participants included in this analysis, 
880  (43%) were men, and median age was 30 years (IQR 
25–38). Table 1 shows baseline characteristics. 
Abbreviated HIV counselling and testing procedures 
took a median of 16 min (IQR 14–20), while the traditional 
sessions took a median of 47 min (IQR 45–50; p<0·0001).
Similar proportions of patients in the abbreviated 
versus traditional group (232/832 [27·9%] vs 251/890 
[28·2%]), reported risky sexual behaviour at any follow-
up interview; the upper bound of the one-sided 95% CI 
for the diﬀ erence was 3·2%. Therefore, because the 
diﬀ erence was less than 6·5%, we rejected the null 
hypothesis of inferiority of abbreviated HIV counselling 
and testing overall, as well as by month of follow-up and 
HIV status (table 2). These results did not diﬀ er 
qualitatively when we used multiple imputation to 
account for missed visits and loss to follow-up (other 
than death), when adjusted for household wealth, and 
when we did a per-protocol analysis (data not shown). We 
did post-hoc analyses of loss to follow-up by counselling 
strategy overall and stratiﬁ ed by HIV status. Loss to 
follow-up was signiﬁ cantly lower in the traditional group 
than in the abbreviated group overall (adjusted hazard 
ratio [HR] 0·61, 95% CI 0·44–0·83), as well as in patients 
with HIV (0·58, 0·38–0·90), while the groups did not 
diﬀ er signiﬁ cantly when considering only HIV-negative 
patients (0·66, 0·42–1·04).
Abbreviated HIV 
counselling and testing
Traditional HIV 
counselling and testing
Diﬀ erence
(95% one-sided 
upper CI)
All participants
At any follow-up visit 232/832 (27·9%) 251/890 (28·2%) –0·3% (3·2%)
At 3 month visit 105/814 (12·9%) 111/861 (12·9%) 0·0% (2·7%)
At 6 month visit 99/808 (12·3%) 114/856 (13·3%) –1·1% (1·6%)
At 9 month visit 96/802 (12·0%) 104/870 (12·0%) 0·0% (2·6%)
At 12 month visit 98/832 (11·8%) 101/890 (11·3%) 0·4% (3·0%)
HIV-positive participants
At any follow-up visit 100/374 (26·7%) 114/402 (28·4%) –1·6% (3·7%)
At 3 month visit 45/363 (12·4%) 50/386 (13·0%) –0·6% (3·4%)
At 6 month visit 44/364 (12·1%) 50/382 (13·1%) –1·0% (3·0%)
At 9 month visit 44/361 (12·2%) 50/393 (12·7%) –0·5% (3·4%)
At 12 month visit 40/374 (10·7%) 49/402 (12·2%) –1·5% (2·3%)
HIV-negative participants
At any follow-up visit 132/458 (28·8%) 137/488 (28·1%) 0·7% (5·6%)
At 3 month visit 60/451 (13·3%) 61/475 (12·8%) 0·5% (4·1%)
At 6 month visit 55/444 (12·4%) 64/474 (13·5%) –1·1% (2·5%)
At 9 month visit 52/441 (11·8%) 54/477 (11·3%) 0·5% (3·9%)
At 12 month visit 58/458 (12·7%) 52/488 (10·7%) 2·0% (5·4%)
Data are n/N (%) unless otherwise stated. Sexual risk behaviour is deﬁ ned as any unprotected intercourse with a 
potentially HIV discordant partner in the 3 months before the interview.
Table 2: Sexual risk behaviours in participants still in follow-up at 12 months
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1003 people were HIV-positive, of whom 378 (38%) 
were men, median age was 31 years (IQR 27–38), and 
median CD4 cell count was 283 cells per mL 
(IQR 130–463). Employment category and baseline 
CD4 cell count were signiﬁ cantly associated with linkage 
to care group in bivariate analysis; therefore, the HRs 
are adjusted for these variables, with CD4 cell count 
modelled as a continuous covariate (table 3).
We recorded no diﬀ erence between linkage groups for 
mortality, receipt of prophylaxis for opportunistic 
infection, or receipt of HIV care (table 3). However, we 
report signiﬁ cant interactions (p<0·10) for two variables: 
time to HIV care was signiﬁ cantly diﬀ erent in women 
only (adjusted HR 0·80, 95% CI 0·66–0·96) and the 
eﬀ ect of linkage to care on time to start of antiretroviral 
treatment was signiﬁ cantly diﬀ erent in men only (0·60, 
0·41–0·87). In men with CD4 cell count of 
250 cells per μL or less, median time to start of 
antiretroviral treatment was 107 days versus 192 days for 
enhanced linkage versus standard linkage (ﬁ gure 2). In 
Enhanced linkage to 
care group
Standard linkage to 
care group
Adjusted* hazard ratio
(95% CI)
p value
Early death (≤90 days) 46/483 (10%) 36/482 (7%) 0·87 (0·56–1·35) 0·53
Men 22/176 (13%) 20/184 (11%) 1·04 (0·56–1·93) 0·90
Women 24/307 (8%) 16/298 (5%) 0·75 (0·39–1·42) 0·37
Death (1 year) 74/483 (15%) 66/482 (14%) 0·97 (0·70–1·36) 0·88
Men 34/176 (19%) 37/184 (20%) 1·23 (0·77–1·97) 0·39
Women 40/307 (13%) 29/298 (10%) 0·80 (0·49–1·29) 0·36
Attended an HIV clinic at most recent medical visit 355/439 (81%) 357/446 (80%) 0·90 (0·77–1·04) 0·17
Men 117/155 (75%) 126/163 (77%) 1·10 (0·85–1·42) 0·48
Women 238/284 (84%) 231/283 (82%) 0·80 (0·66–0·96) 0·02
Received co-trimoxazole 416/439 (95%) 416/446 (93%) 0·95 (0·83–1·09) 0·48
Men 142/155 (92%) 152/163 (93%) 1·07 (0·85–1·35) 0·58
Women 274/284 (96%) 264/283 (93%) 0·89 (0·75–1·06) 0·19
Received antiretroviral therapy (baseline CD4 ≤250 cells per μL) 157/202 (78%) 130/183 (71%) 0·77 (0·60–0·97) 0·03
Men 66/81 (81%) 47/76 (62%) 0·60 (0·41–0·87) 0·008
Women 91/121 (75%) 83/107 (76%) 0·95 (0·70–1·30) 0·76
Interaction between participant sex and linkage to care group, with adjusted models, p≥0·10 for all except: attended HIV clinic (p=0·08) and received antiretroviral therapy 
(p=0·04). *Adjusted for continuous baseline CD4 cell count, and stratiﬁ ed by baseline employment category.  
Table 3: Cause-speciﬁ c outcomes by linkage to care in HIV-positive participants
Figure 2: Kaplan-Meier curves of time to start of antiretroviral therapy in patients with CD4 cell count less than 250 cells per μL
In men (A) and women (B). Adjusted for baseline CD4 cell count and employment.
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a post-hoc analysis, we recorded no diﬀ erence between 
abbreviated and traditional HIV counselling and testing 
in time to HIV care, controlling for linkage to care 
group (data not shown).
Discussion
HIV testing and linkage to care are essential for ﬁ ghting 
the HIV epidemic, and evidence-based methods for 
increasing coverage of testing and accelerating linkage to 
care are needed. We report that abbreviated counselling 
was as eﬀ ective as full length counselling in reducing 
sexual risk behaviour in both HIV-infected and 
uninfected individuals, and was roughly 30 min shorter 
in duration (panel). This ﬁ nding has important 
implications for policy and practice in terms of scale-up 
of HIV counselling and testing services.1 Provider 
initiation increases uptake of HIV counselling and 
testing, and evidence suggests that it is no worse than 
other approaches to HIV testing in terms of ensuring 
informed consent, conﬁ dentiality, and counselling.12,22,29 
Our ﬁ ndings extend these results by showing that an 
abbreviated counselling protocol can be used without 
fear of compromising the reductions in HIV risk 
behaviours aﬀ orded by detailed counselling. Adoption of 
abbreviated counselling could alleviate many of the 
burdens on medical professionals, while retaining value 
for patients. Time saved in counselling will probably 
reduce counsellor and provider eﬀ ort and, eventually, the 
cost of provider-initiated HIV counselling and testing.30 
Our study was not designed to assess the cost-
eﬀ ectiveness of provider-initiated HIV counselling and 
testing and additional assessment is needed. In addition, 
traditional counselling was associated with improved 
retention in the study among HIV-positive people, which 
may warrant further investigation.
Enhanced linkage signiﬁ cantly decreased time to start 
of antiretroviral treatment in men and entry into HIV 
care in women. Early entry into care and treatment can 
increase survival and decrease secondary HIV 
transmission.1 The diﬀ erence by sex was surprising, but 
could be because, for women, enhanced linkage was 
helpful for initial clinic attendance, whereas for men, 
enhanced linkage did not increase the rate of getting to 
the clinic but instead served to retain them in clinic long 
enough to start treatment. Men access health care (for 
HIV or otherwise) less frequently and later than do 
women and have poorer retention in care than women.31,32 
Thus, introducing men to the clinic could have an 
important eﬀ ect on early treatment initiation.1 Enhanced 
linkage had no eﬀ ect on receipt of prophylaxis for 
opportunistic infections; this ﬁ nding is not surprising, 
since co-trimoxazole prophylaxis is cheap and nearly 
universal in HIV clinics in Uganda. The absence of an 
eﬀ ect on survival might be because follow-up was only 
for 1 year; longer-term eﬀ ects are plausible.
Our study had several limitations. The main 
outcomes—other than mortality—were self-assessed. 
Risky sexual behaviour at follow-up might have been 
under-reported, and those who received traditional, 
lengthier counselling might have been more likely to 
under-report risky behaviour because of social 
desirability. However, under-reporting in the traditional 
group would still support our conclusion that abbreviated 
counselling was no worse than traditional counselling in 
terms of sexual risk. To verify self-reported antiretroviral 
treatment, we reviewed patients’ charts when treatment 
regimens were not speciﬁ ed in the study survey. For 
patients who received HIV care at Mulago Hospital, we 
veriﬁ ed that most (79%) agreed with the chart review to 
within 3 months. We might have underestimated the rate 
Panel: Research in context
Systematic review
Because no previous studies had compared traditional and abbreviated HIV counselling 
and testing head to head before this study began in 2008, a systematic review was not 
possible. At the time of ﬁ nal data analysis, we reviewed articles that assessed access to HIV 
care and risk reduction after provider-initiated HIV testing and counselling, and models of 
provider-initiated counselling. We searched PubMed for articles published in English up to 
July 20, 2013. The search terms included: “provider initiated HIV counseling and testing”, 
“provider initiated HIV testing and counseling” “routine HIV counseling and testing”, 
“linkage to care”, “access to care”, “risk reduction”, “HIV risk behavior”, “brief HIV 
counseling”, “abbreviated HIV counseling“, and “detailed HIV counseling”. Our search 
returned 61 articles; nine of which assessed linkage to care or risk reduction with 
provider-initiated HIV testing and counselling or compared provider-initiated HIV testing 
and counselling with other approaches. We excluded articles that described only uptake of 
testing or HIV testing and counselling processes. Three systematic reviews describe 
increases in uptake of testing after the introduction of provider-initiated schemes.12,22,23 
Two articles12,13 reported increased condom use after provider-initiated HIV testing and 
counselling while access to care and other outcomes were mixed. Two studies24,25 
compared access to care by testing mode (provider-initiated vs voluntary HIV testing and 
counselling) in people who tested HIV-positive; both reported lower access to care in 
those receiving provider-initiated HIV testing and counselling and one reported lower 
odds of starting treatment and lower odds of retention in care for provider-initiated 
approaches.24 However, other articles reported increased access to care and treatment 
after provider-initiated HIV testing and counselling.26–28 Challenges to implementation of 
provider-initiated HIV testing and counselling—eg, logistics, data systems, human 
resources, and management—were reported.23 We found no articles that examined 
models of provider-initiated counselling speciﬁ cally comparing the eﬀ ectiveness of brief 
versus detailed HIV counselling.
Interpretation
Studies show some moderate risk reduction with voluntary HIV testing and counselling, 
raising concerns that brief counselling through provider-initiated HIV testing and 
counselling could compromise these outcomes. However, no study had evaluated these 
outcomes for brief counselling in comparison to detailed counselling. To our knowledge, 
our trial is the ﬁ rst to assess brief versus detailed provider-initiated counselling. The 
ﬁ ndings show that unprotected sex with an HIV discordant or status unknown partner 
was similar with both approaches and that enhancing linkage to care reduced the time to 
start of treatment for men who were eligible for treatment and time to HIV care for 
women. These ﬁ ndings indicate a need to focus more on the linkage to care and retention 
after testing as opposed to providing detailed pre-test and post-test counselling in 
provider-initiated HIV testing and counselling.
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of receiving HIV care, because we asked about attending 
HIV care only at the participant’s most recent medical 
visit. This misclassiﬁ cation could have resulted in a bias 
to the null.33 Another limitation was the diﬀ erent loss to 
follow-up in each counselling group. If greater loss to 
follow-up in the abbreviated counselling group was also 
associated with greater risky sexual behaviour, we could 
have incorrectly rejected inferiority. However, our results 
did not diﬀ er substantially when we used multiple 
imputation to account for missed visits. Another 
limitation is the use of a single site. However, many 
features of this setting—high HIV prevalence, 
widespread risky sexual behaviour, and persistently 
limited access to counselling, testing, care, and treatment 
services—are common to other health-care settings. 
The ﬁ ndings cannot be extended to home-based and 
community-based testing.
In conclusion, abbreviated HIV counselling and testing 
saves time and does not adversely aﬀ ect risk behaviour; 
however, increased time spent with people who are HIV-
positive might increase retention in care. Programmes 
that improve linkage to care can decrease the time to 
visiting an HIV clinic for women and time to start of HIV 
treatment for men. These ﬁ ndings suggest that shifting 
human resources previously devoted to traditional HIV 
risk reduction counselling to enhanced linkage to care 
could lead to more eﬀ ective HIV prevention through 
improved treatment-mediated viral suppression without 
increasing HIV transmission risk behaviour.
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